Dr. Gentzler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1240 Lee St
Charlottesville, VA 22908Phone+1 434-924-9333Fax+1 434-243-6086
Education & Training
- McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 2011 - 2014
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 2008 - 2011
- Lewis Katz School of Medicine at Temple UniversityClass of 2008
- Davidson CollegeBS, 2000 - 2004
Certifications & Licensure
- VA State Medical License 2014 - 2026
- IL State Medical License 2011 - 2014
- PA State Medical License 2008 - 2011
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Jul 08
- Consolidation Pembrolizumab Following Chemoradiation in Patients With Inoperable/Unresectable Stage III NSCLC Start of enrollment: 2015 Mar 09
- Carboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLC Start of enrollment: 2015 Jun 04
- Join now to see all
Publications & Presentations
PubMed
- 71 citationsAmivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MA...A Passaro, J Wang, Y Wang, S-H Lee, B Melosky
Annals of Oncology. 2024-01-01 - 4 citationsPhase I Study of Entinostat, Atezolizumab, Carboplatin, and Etoposide in Previously Untreated Extensive-Stage Small Cell Lung Cancer, ETCTN 10399.Ryan D Gentzler, Liza C Villaruz, John C Rhee, Bethany Horton, Joseph Mock
The Oncologist. 2023-11-02 - 85 citationsA phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non–small cell lung cancer: Hoosier cancer ...Greg Andrew Durm, Salma K. Jabbour, Sandra Althouse, Ziyue Liu, Ahad Ali Sadiq
Cancer. 2020-10-01
Press Mentions
- UVA Cancer Center 1st in State to Offer New Lung Cancer TreatmentAugust 19th, 2024
- UVA Cancer Center Pioneers New Lung Cancer Treatment in VirginiaAugust 19th, 2024
- UVA Cancer Center First in Virginia to Offer New Lung Cancer TreatmentAugust 19th, 2024
- Join now to see all
Professional Memberships
- Member
- International Association for the Study of Lung Cancer (IASLC)Member
External Links
- UVA Physician Profilehttp://cancer.uvahealth.com/findadoctor/profile/Ryan-Gentzler
- UVA Cancer Centerhttp://cancer.uvahealth.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: